Microvascular Therapeutics Has Received Funds from the National Heart, Lung and Blood Institute
- MVT
- Jul 30, 2021
- 0 min read
top of page
Search
Recent Posts
See AllBoston, MA – June 18, 2025 – Microvascular Therapeutics (MVT) is pleased to announce Founder and CEO, Dr. Evan Unger, as speaker on the...
May 14th, 2025 Salt Lake City, Utah: Microvascular Therapeutics, Inc. (MVT), a biotechnology company, announced that it has completed...
Tucson, AZ & Mountain View, CA – Microvascular Therapeutics (MVT), a pioneering healthcare research and development company, is pleased...
bottom of page
Commentaires